CX Institutional Invests $36,000 in UiPath, Inc. (NYSE:PATH)

CX Institutional bought a new position in UiPath, Inc. (NYSE:PATH) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,499 shares of the company’s stock, valued at approximately $36,000.

Other large investors have also bought and sold shares of the company. Smartleaf Asset Management LLC grew its holdings in UiPath by 88.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company’s stock worth $31,000 after acquiring an additional 1,152 shares during the last quarter. Versant Capital Management Inc raised its position in UiPath by 198.6% in the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company’s stock worth $31,000 after purchasing an additional 1,970 shares during the last quarter. First Horizon Advisors Inc. lifted its holdings in UiPath by 47.8% during the 4th quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company’s stock worth $32,000 after buying an additional 804 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in UiPath by 141.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company’s stock worth $38,000 after buying an additional 1,742 shares in the last quarter. Finally, V Square Quantitative Management LLC boosted its position in UiPath by 33.4% in the 4th quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company’s stock valued at $39,000 after buying an additional 759 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors.

UiPath Trading Down 0.4%

NYSE:PATH opened at $12.43 on Wednesday. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $15.93. The stock has a 50-day moving average price of $12.11 and a two-hundred day moving average price of $12.63. The stock has a market cap of $6.65 billion, a price-to-earnings ratio of -103.54, a PEG ratio of 16.35 and a beta of 1.06.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.01. The business had revenue of $356.62 million for the quarter, compared to analysts’ expectations of $332.17 million. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. UiPath’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.13 EPS. Sell-side analysts forecast that UiPath, Inc. will post -0.17 earnings per share for the current year.

Insider Buying and Selling

In other news, CAO Hitesh Ramani sold 12,500 shares of the firm’s stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $10.19, for a total transaction of $127,375.00. Following the completion of the transaction, the chief accounting officer now directly owns 314,891 shares of the company’s stock, valued at $3,208,739.29. This trade represents a 3.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Ashim Gupta sold 98,795 shares of UiPath stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $12.01, for a total transaction of $1,186,527.95. Following the completion of the sale, the chief financial officer now owns 987,322 shares in the company, valued at $11,857,737.22. This trade represents a 9.10% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 23.19% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on PATH. Scotiabank upped their price target on UiPath from $12.00 to $13.00 and gave the company a “sector perform” rating in a research note on Friday, May 30th. Wells Fargo & Company reiterated an “equal weight” rating on shares of UiPath in a research report on Friday, May 30th. Mizuho dropped their price target on shares of UiPath from $12.00 to $11.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th. Royal Bank Of Canada lifted their target price on shares of UiPath from $13.00 to $15.00 and gave the stock a “sector perform” rating in a report on Friday, May 30th. Finally, Morgan Stanley increased their price target on UiPath from $12.00 to $15.00 and gave the company an “equal weight” rating in a research note on Monday, June 2nd. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $13.83.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.